Showing results (2871-2880 of 6,973) with videos related to
Sort By:
Pageof 698
Histopathology|January 8, 2014
Cardiac mucosa at the gastro-oesophageal junction: indicator of gastro-oesophageal reflux disease? Data from a prospective central European multicentre study on histological and endoscopic diagnosis of oesophagitis (histoGERD trial)Cord Langner, Nora I Schneider, Wolfgang Plieschnegger, et al.Histopathology|June 4, 2014
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic valueElizabeth G Demicco, Genevieve M Boland, Kari J Brewer Savannah, et al.Histopathology|May 1, 1987
Cytokeratin expression in smooth muscle and smooth muscle tumoursD C Brown, J M Theaker, P M Banks, et al.Histopathology|January 22, 2014
A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sacFrancisco F Nogales, Enoe Quiñonez, Laura López-Marín, et al.Histopathology|September 1, 1987
Chromolipid-induced portal lymphadenopathy in primary biliary cirrhosisE W Benbow, R F McMahonHistopathology|April 8, 2021
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphomaYuichiro Hamamoto, Yoji Kukita, Masanori Kitamura, et al.Histopathology|April 8, 2021
Adenomyoepithelioma of the breast: a proposal for classificationEmad Rakha, Puay Hoon Tan, Ian Ellis, et al.Histopathology|July 12, 2020
Mouse double minute 2 amplification in oesophageal squamous cell carcinoma is associated with better outcomeDongxian Jiang, Lingli Chen, Jie Huang, et al.Histopathology|August 9, 2020
Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinomaSatoshi Yamashita, Hiroyuki Abe, Akiko Kunita, et al.Pageof 698